SCHEMBL4333218

SCHEMBL4333218

CCOC(=O)C(Cc1ccc(N)c(OC)c1)OC(C)C

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.47
LDHA P00338 1/20 0.42
FOS P01100 1/20 0.40
TTR P02766 1/20 0.40
JUN P05412 1/20 0.40
NR3C1 P04150 1/20 0.40
HSD17B1 P14061 1/20 0.40
HSD17B2 P37059 1/20 0.40
MET P08581 2/20 0.39
GAA P10253 1/20 0.39
LMNA P02545 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALOX15 P16050 3/20 0.37
ALOX12 P18054 1/20 0.37
CA12 O43570 2/20 0.37
CA1 P00915 2/20 0.37
CA2 P00918 2/20 0.37
CA9 Q16790 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4329066 0.90 GAA (0.47) ALDH1A1LDHAGAALMNASMN1; SMN2
SCHEMBL3369599 0.86 HSD17B2 (0.57) ALDH1A1FOSTTRJUNNR3C1
SCHEMBL4333251 0.84 ALOX15 (0.57) LDHAFOSTTRJUNNR3C1
SCHEMBL4329833 0.83 ALOX15 (0.46) ALDH1A1LDHALMNASMN1; SMN2ALOX15
SCHEMBL6495800 0.83 LDHA (0.40) ALDH1A1LDHALMNASMN1; SMN2ALOX15
SCHEMBL4338102 0.82 NPC1 (0.48) ALDH1A1GAASMN1; SMN2ALOX15
SCHEMBL4329462 0.81 ALOX15 (0.44) ALDH1A1LDHALMNASMN1; SMN2ALOX15
SCHEMBL6498892 0.81 PPARA (0.44) LDHAALOX15ALOX12
SCHEMBL6506184 0.81 ALOX15 (0.46) ALDH1A1LDHALMNASMN1; SMN2ALOX15
SCHEMBL6495805 0.81 PKM (0.44) ALDH1A1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-7544835-B2 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-09 US disclosed
US-20040102634-A1 Carboxylic acid derivative and salt thereof EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-05-27 US disclosed
EP-1380562-A1 CARBOXYLIC ACID DERIVATIVE AND SALT THEREOF Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102634-A1 Carboxylic acid derivative and salt thereof GPR119, IRS1, SLC5A1 ALDH1A1 844/4885LDHA 745/4885FOS 1469/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.